The Japanese pharmaceuticals market now looks set for significant consolidation following
the agreement between Yamanouchi and Fujisawa to merge in 2005. New government
regulation and generic competition in Japan are attracting Western pharma companies, while
limited growth opportunities domestically are driving Japanese pharma companies to expand
operations abroad...